Skip to main content

Want a detailed portfolio tracker?

Atyr Pharma (ATYR) P/E (2015 - 2026)

Atyr Pharma (ATYR) P/E from May 7, 2015 to Jul 21, 2026. The TTM Atyr Pharma (ATYR) P/E is -0.67. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Atyr Pharma (ATYR)

YearP/EChange
2026-0.67-33.06%
2025-1.00-76.57%
2024-4.27+169.26%
2023-1.59+18.71%
2022-1.34-70.17%
2021-4.48+85.67%
2020-2.41+1036.35%
2019-0.21-52.75%
2018-0.45-85.84%
2017-3.17+62.79%
2016-1.95-78.13%
2015-8.91N/A

Comparison Atyr Pharma (ATYR) P/E with competitors

Atyr Pharma (ATYR) P/E is -0.67.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.00-100.64%
ENLVEnlivex Ltd0.07-111.17%
FGENFibroGen Inc0.24-135.84%
CHRSCoherus Biosciences Inc0.85-226.68%
FBIOFortress Biotech Inc0.95-241.68%
ORMPOramed Pharmaceuticals Inc1.50-324.39%
AGENAgenus Inc3.01-549.31%
INVAInnoviva Inc3.15-570.86%
VXRTVaxart Inc3.55-629.94%
CRMDCorMedix Inc3.63-641.69%
CVACCureVac N.V.4.45-763.69%
GLPGGalapagos NV4.86-825.38%
SRPTSarepta Therapeutics Inc4.88-828.85%
ABEOAbeona Therapeutics Inc5.39-904.30%
ABUSArbutus Biopharma Corp5.60-935.37%
ZVRAZevra Therapeutics Inc5.89-978.90%
SPROSpero Therapeutics Inc6.23-1029.84%
CGENCompugen Ltd6.31-1042.61%
RIGLRigel Pharmaceuticals6.87-1125.93%
SLXNSilexion Therapeutics Corp7.30-1189.23%
OMEROmeros Corporation9.26-1482.24%
PLXProtalix BioTherapeutics Inc10.89-1725.92%
ACADAcadia Pharmaceuticals Inc11.73-1850.96%
TBPHTheravance Biopharma Inc12.26-1930.62%
ADMAAdma Biologics Inc12.42-1953.91%
HRMYHarmony Biosciences Holdings Inc13.82-2163.22%
SABSSAB Biotherapeutics Inc14.14-2210.40%
NAGENiagen Bioscience Inc14.82-2312.21%
INCYIncyte Corp15.82-2462.16%
REGNRegeneron Pharmaceuticals Inc15.86-2467.25%
PBYIPuma Biotechnology Inc17.32-2685.07%
CPRXCatalyst Pharmaceuticals Inc17.44-2703.53%
EXELExelixis Inc17.54-2718.26%
TGTXTG Therapeutics Inc18.97-2931.46%
MDXGMimedx Group Inc20.55-3168.30%
XOMAXOMA Royalty Corp22.87-3515.07%
ARGXArgen X SE24.30-3727.56%
CTMXCytomX Therapeutics Inc24.82-3805.66%
XOMAOXOMA Royalty Corp25.34-3883.84%
HALOHalozyme Therapeutics Inc25.62-3925.48%
XOMAPXOMA Royalty Corp25.67-3932.41%
VRTXVertex Pharmaceuticals Inc27.99-4279.46%
RPRXRoyalty Pharma plc - Class A28.69-4382.89%
SLNOSoleno Therapeutics Inc29.02-4431.83%
ASNDAscendis Pharma A/S30.09-4591.61%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5760.06%
APLSApellis Pharmaceuticals Inc39.02-5925.66%
BMRNBiomarin Pharmaceutical Inc42.21-6402.00%
KRYSKrystal Biotech Inc45.34-6869.54%
ONCBeiGene Ltd69.54-10482.02%
PHARPharming Group N.V.75.03-11300.92%
TECHBio-Techne Corp101.96-15321.85%
VCELVericel Corp109.92-16510.67%
ALNYAlnylam Pharmaceuticals Inc117.96-17711.56%
GMABGenmab140.29-21044.67%
TLXTelix Pharmaceuticals Ltd162.15-24308.56%
CORTCorcept Therapeutics Inc212.86-31878.50%